A Randomized, Controlled Trial to Determine Whether Continued Ribavirin Monotherapy in Hepatitis C Virus-Infected Patients Who Responded to Interferon-Ribavirin Combination Therapy Will Enhance Sustained Virologic Response

Autor:	Shiffman, Mitchell L., Hofmann, Charlotte M., Sterling, Richard K., Luketic, Velimir A., Contos, Melissa J., Sanyal, Arun J.
Zdroj:	The Journal of Infectious Diseases, 2001 Aug . 184(4), 405-409.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/30137182 Zobrazit plný text záznamu